* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhu Healthcare Holding Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongzhu Healthcare Holding Co FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhongzhu Healthcare Holding Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Zhongzhu Healthcare Holding Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongzhu Healthcare Holding Co (SHSE:600568) has a FCF Margin % of -16.97% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zhongzhu Healthcare Holding Co and its competitors. According to the industry distribution chart, Zhongzhu Healthcare Holding Co ranks #597 out of 955 companies in the Drug Manufacturers industry, placing it in the top 62.5%.
Is Zhongzhu Healthcare Holding Co's FCF Margin % too high?
Zhongzhu Healthcare Holding Co's current FCF Margin % is -16.97%. Based on the distribution chart, Zhongzhu Healthcare Holding Co ranks #597 out of 955 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zhongzhu Healthcare Holding Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhu Healthcare Holding Co's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zhongzhu Healthcare Holding Co ranks #597 out of 955 companies for FCF Margin %. This places Zhongzhu Healthcare Holding Co in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zhongzhu Healthcare Holding Co and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongzhu Healthcare Holding Co's current FCF Margin % is -16.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhu Healthcare Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co (SHSE:600568) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.88, compared to a current price of ¥2.25 — trading 19.7% above its estimated fair value. The current FCF Margin % is -16.97%. Zhongzhu Healthcare Holding Co's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Zhongzhu Healthcare Holding Co (SHSE:600568), the current FCF Margin % is -16.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued.
The current stock price of ¥2.25 is trading 19.7% above its estimated GF Value™ of ¥1.88.
GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.
Key valuation signals for SHSE:600568:
FCF Margin %: -16.97%
GF Value™: ¥1.88 vs. price of ¥2.25 (19.7% above fair value)
No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongzhu Healthcare Holding Co Business Description
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
55GF Score
Get the complete analysis for SHSE:600568
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600568 has been successfully added to your 
